EurekAlert! -
30 Apr 2020 06:00
(University of California - Los Angeles Health Sciences) UCLA is one of seven sites participating in a clinical trial investigating whether hydroxychloroquine, a commonly used anti-malarial and autoimmune drug, can prevent infection with COVID-19.
Share this Article